1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Contineum Therapeutics, Inc. Class A Common Stock

Contineum Therapeutics, Inc. Class A Common Stock

CTNM
Contineum Therapeutics, Inc. Class A Common StockUS flagNASDAQ Global Select
12.48
USD
+0.10
- -
466.58MMarket Cap

Income Statement (USD)

APIChat
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
50
- -
- -
+ Sales & Services Revenue
- -
- -
50
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-50
- -
- -
- Operating Expenses
29
23
34
51
68
+ Selling, General & Admin
6
6
6
12
17
+ Research & Development
22
17
28
38
52
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-29
-23
16
-51
-68
- Non-Operating (Income) Loss
- -
2
-7
-9
-8
+ Interest Expense, Net
- -
- -
-4
-9
-8
+ Interest Expense
- -
- -
- -
- -
- -
- Interest Income
- -
1
5
9
8
+ Other Non-Op (Income) Loss
- -
2
-3
- -
- -
Pretax Income
-29
-24
23
-42
-60
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-29
-24
23
-42
-60
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-29
-24
23
-42
-60
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-29
-24
23
-42
-60
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-29
-24
23
-42
-60
EBIT
-29
-23
16
-51
-68
EBITDA
-28
-22
16
-51
-68
EBITDA Margin (%)
- -
- -
32.54
- -
- -
EBITA
-29
-23
16
-51
-68
Gross Margin (%)
- -
- -
100
- -
- -
Operating Margin (%)
- -
- -
32.15
- -
- -
Profit Margin (%)
- -
- -
45.44
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
17
17
27
19
- -
Basic EPS, GAAP
-1.74
-1.45
0.84
-2.18
- -
Basic EPS from Cont Ops
-1.74
-1.45
0.84
-2.18
- -
Diluted Weighted Avg Shares
18
18
27
19
- -
Diluted EPS, GAAP
-1.63
-1.37
0.84
-2.18
- -
Diluted EPS from Cont Ops
-1.63
-1.37
0.84
-2.18
- -

Balance Sheet (USD)

APIChat
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
70
48
128
206
268
+ Cash, Cash Equivalents & STI
69
47
125
205
263
+ Cash & Cash Equivalents
5
6
16
22
76
+ ST Investments
64
42
110
183
187
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
3
2
5
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
2
3
6
9
+ Property, Plant & Equip, Net
1
2
1
6
8
+ Property, Plant & Equip
2
3
3
8
10
- Accumulated Depreciation
1
1
1
2
2
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
- -
- -
Total Assets
71
51
130
213
277
+ Payables & Accruals
1
1
3
5
3
+ Accounts Payable
1
- -
1
2
1
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
2
3
2
+ ST Debt
1
5
- -
1
2
+ ST Borrowings
1
4
- -
- -
- -
+ ST Finance Leases
- -
1
- -
1
2
+ Other ST Liabilities
1
1
2
3
5
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
2
3
5
Total Current Liabilities
4
8
5
10
10
+ LT Debt
4
1
- -
5
6
+ LT Borrowings
4
- -
- -
- -
- -
+ LT Finance Leases
- -
1
- -
5
6
+ Other LT Liabilities
134
136
193
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
134
136
193
- -
- -
Total Noncurrent Liabilities
138
136
193
5
6
Total Liabilities
141
144
198
15
16
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
3
5
7
315
438
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
3
5
7
315
438
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-74
-98
-75
-117
-177
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-71
-93
-68
198
261
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-71
-93
-68
198
261
Total Liabilities & Equity
71
51
130
213
277
Shares Outstanding
27
27
27
26
37
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
2
1
6
8
Net Debt
- -
-2
-16
-22
-76
Net Debt to Equity
-0.39
1.74
22.85
-11.08
-28.97
Tangible Common Equity Ratio
-100.53
-184.08
-52.1
93.06
94.34
Current Ratio
18.99
6.41
23.29
20.69
27.5
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-29
-24
23
-42
-60
+ Depreciation & Amortization
- -
- -
- -
- -
- -
+ Non-Cash Items
2
5
-3
4
10
+ Stock-Based Compensation
2
2
2
7
10
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
1
3
-5
-3
- -
+ Chg in Non-Cash Work Cap
- -
-1
-1
5
-6
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
1
-3
+ Inc (Dec) in Accts Payable
- -
- -
2
3
-1
+ Inc (Dec) in Other
- -
-1
-1
1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-26
-20
19
-33
-55
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-1
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
108
112
+ Increase in Capital Stock
- -
- -
- -
108
112
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
-65
22
-65
-69
-3
+ Dec in LT Investment
2
87
77
157
159
+ Inc in LT Investment
-67
-65
-142
-226
-163
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-65
22
-66
-70
-4
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
-2
-8
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
-2
-8
- -
- -
+ Other Financing Activities
80
1
64
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
80
-1
56
109
113
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
-11
1
10
6
54
EBITDA
-28
-22
16
-51
-68
EBITDA Margin (%)
- -
- -
32.54
- -
- -
Free Cash Flow
-26
-20
19
-33
-56
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
19
- -
- -
Free Cash Flow to Equity
- -
-23
11
-33
-56
Free Cash Flow per Basic Share
-1.59
-1.21
0.7
-1.72
- -
Price/Free Cash Flow
- -
- -
- -
-8.77
- -
Cash Flow to Net Income
0.91
0.83
0.85
0.78
0.92
Capital Expenditures
- -
- -
- -
-1
- -